共 50 条
- [1] Pharmacokinetic and Pharmacodynamic Modeling of MOD-4023, a Long-Acting Human Growth Hormone, in Growth Hormone Deficiency Children HORMONE RESEARCH IN PAEDIATRICS, 2017, 87 (05): : 324 - 332
- [2] 2nd Year Pharmacokinetic and Pharmacodynamic Modeling of Long-Acting Human Growth Hormone (MOD 4023) in Growth Hormone Deficient Children HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 375 - 375
- [3] Pharmacokinetics, Pharmacodynamics, and Safety of a Long-Acting Human Growth Hormone (MOD-4023) in Healthy Japanese and Caucasian Adults CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (05): : 554 - 563
- [4] Immunogenicity Results of Once-Weekly Administration of CTP-Modified Human Growth Hormone (MOD-4023): A Phase 2 Study in Children with Growth Hormone Deficiency HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 371 - 371
- [5] Batch-to-Batch Consistency of a Highly O-Glycosylated Long-Acting Human Growth Hormone (MOD-4023) HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 95 - 95
- [8] RELIABLE MONITORING OF WEEKLY IGF-I LEVELS DURING LONG-ACTING GROWTH HORMONE THERAPY WITH SOMAPACITAN HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 295 - 295
- [9] Estimating the weekly average IGF-1 from a single IGF-1 sample in children with Growth Hormone Deficiency (GHD) treated with lonapegsomatropin HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 2): : 76 - 76
- [10] GROWTH-HORMONE ADMINISTRATION INCREASES IGF-1 LEVELS IN TRAUMA PATIENTS FASEB JOURNAL, 1993, 7 (04): : A616 - A616